Related Experiment Video
Updated: Jul 9, 2026

Operant Procedures for Assessing Behavioral Flexibility in Rats
Published on: February 15, 2015
Lack of dopaminergic modulation of cognitive flexibility
Shawn F Smyth1, David Q Beversdorf
1Department of Neurology, The Ohio State University, Columbus, OH 43210, USA.
Objective:
To evaluate performance on a cognitive flexibility task after administration of a dopaminergic agonist.
Background:
L-3,4-dihydroxyphenylalanine, which is converted into dopamine and norepinephrine, results in a restriction of the semantic network in priming experiments. Recent evidence suggests that flexibility of access to semantic networks in problem solving is mediated by the noradrenergic system. We wished to determine if dopaminergic agonists also affect this type of cognitive flexibility.
Methods:
Eighty-four subjects were tested twice on an anagram task, once 1 hour after bromocriptine (dopamine agonist) and once 1 hour after placebo administration.
Results:
No difference was detected between placebo and bromocriptine on anagram performance.
Conclusions:
Therefore, modulation of this type of cognitive flexibility does not seem to be mediated by the dopaminergic system. This suggests that the noradrenergic modulation of cognitive flexibility previously reported does not seem to extend to the dopaminergic system among catecholamines.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

